The Quantellect read.As of Nov 19, 2026, 3 active firms cover Rapid Micro Biosystems Inc: 3 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets range widely, $3.00 to $7.00 (about 2.3x), a sign of real disagreement on valuation. The average target of $5.00 sits 580% above the current $0.74. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.20 next quarter toward $-0.74 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy3100%
Neutral00%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$5.00
+579.8% upside
Average target across 3 active firms as of Nov 19, 2026 vs $0.74 current
Highest Target$7.00
Average Target$5.00
Lowest Target$3.00
Detailed analyst forecasts for RPID
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 3 of 3 active firms rate RPID a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
RPID EPS & revenue forecast
EPS · NEXT QUARTER
$-0.20
Range $-0.20 – $-0.20 · 1 analysts · -35% YoY
Next period, 1 analysts expect Rapid Micro Biosystems Inc to earn $-0.20 a share (range $-0.20 – $-0.20), versus $-0.31 a year earlier. Full-year consensus is $-0.94, growing to $-0.74 the year after.
REVENUE · NEXT QUARTER
$9.9M
Range $9.9M – $9.9M · 1 analysts · +24% YoY
Revenue is expected to reach $9.9M (range $9.9M – $9.9M), +23.7% year-over-year. Full-year consensus is $38.1M, rising to $45.6M next year.
Top analysts covering Rapid Micro Biosystems Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on RPID.
#1
TF
Thomas Flaten
Lake Street · Rank #306
Buy
$7.00+851.7% to target
Overall win rate
40%
+ Follow
#2
Paul Knight
Keybanc · Rank #394
Buy
$5.00+579.8% to target
Overall win rate
39%
+ Follow
#3
BS
Brendan Smith
TD Cowen
Buy
No targeton RPID
Coverage
—
+ Follow
RPID stock forecast FAQ
What is RPID's average 12-month price target?+
The 3 active firms with a live target average $5.00 for Rapid Micro Biosystems Inc over the next 12 months, ranging from a $7.00 high to a $3.00 low, as of Nov 19, 2026.
Is RPID stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for RPID?+
The Street-high target is $7.00 (Lake Street), and the Street-low is $3.00 (Roth Capital). The average of all 3 active-firm targets is $5.00.
How many active Wall Street firms cover RPID?+
3 active firms have a recognized rating on Rapid Micro Biosystems Inc as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering RPID?+
Among analysts who currently cover RPID, Thomas Flaten of Lake Street has the strongest overall Quantellect track record (Rank #306). Their current call is Buy with a $7.00 target.
What is Rapid Micro Biosystems Inc's projected EPS for next quarter?+
The consensus estimate is $-0.20 per share (range $-0.20 – $-0.20) across 1 analysts. Full-year EPS is projected at $-0.94, rising to $-0.74 the following year.
How much revenue is Rapid Micro Biosystems Inc expected to report next quarter?+
Consensus revenue is $9.9M (range $9.9M – $9.9M). Full-year revenue is projected at $38.1M, growing to $45.6M next year.
Have analysts been upgrading or downgrading RPID lately?+
As of Nov 19, 2026, 3 of 3 active firms rate RPID a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their RPID calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.